The core difference is regulatory status, not chemistry
It is not intended for human or animal use of any kind, including medical, nutritional, or cosmetic applications
Mechanism of Action Retatrutide operates as a triple agonist, effectively stimulating GLP-1, GIP, and glucagon receptors
doi:10 } : CS1 maint: DOI inactive as of October 2025 (link) International Journal of Hygiene and Environmental Health
Strategies that deplete GSH, such as using inhibitors like BSO which is inhibitor of -glutamylcysteine synthetase (-GCS) , the rate-limiting enzyme in glutathione (GSH) synthesis or by combining prodrug activation with GSH depletion in nanosystems, have shown promise in overcoming MDR and improving chemotherapy effectiveness [72]